Abbott Reports Q2 2023 Revenue Growth Exceeding Estimates Despite COVID-19 Dip
US-based life sciences firm Abbott (NYSE: ABT) has released its financial results for the second...
Fineline Cube
Jiangsu Simcere Pharmaceutical Gets NMPA Approval for Quviviq, Anti-Insomnia Drug
Jiangsu Simcere Pharmaceutical Co., Ltd (HKG: 2096) has announced the receipt of clinical trial approval...
Livzon Pharmaceutical Secures Licensing Agreement for Synergy Pharma’s HHT120 in Greater China
China-based Livzon Pharmaceutical Group Inc. (HKG: 1513) has announced a licensing agreement with fellow Chinese...
Alibaba Health and Daiichi Sankyo Partner to Innovate in Digital Healthcare Services
China’s Alibaba Health Information Technology Ltd (HKG: 0241) has entered into a strategic partnership with...
Pfizer’s GBS Vaccine Candidate GBS6 Shows Promise in Phase II Maternal Immunization Study
Pfizer (NYSE: PFE) has this week published the Phase II data for its Group B...
US Merger Guidelines Updated: Public Comment Sought on Antitrust Law Changes
The United States has published an update to its merger and acquisition guidelines, seeking public...
Merck and Telix Pharmaceuticals Initiate Phase I Study for CAIX-Expressing Tumors Therapy
A Phase I study assessing the combination of German-major Merck’s (NYSE: MRK) DNA-PK inhibitor, peposertib,...
Janssen’s Sirturo (Bedaquiline) Expands Indication to Include Adolescents with MDR-TB
The Janssen unit of Johnson & Johnson (J&J; NYSE: JNJ) has announced that the National...
Chongqing Zhifei Biological Launches Phase I Clinical Trial for Group B Meningococcal Vaccine
Chongqing Zhifei Biological Co., Ltd (SHE: 300122) has announced the commencement of a Phase I...
Chipscreen Pharmaceutical’s Epidaza Granted Priority Status for DLBCL Treatment in China
The Center for Drug Evaluation (CDE) website has announced that Shenzhen Chipscreen Biosciences Co., Ltd’s...
HutchMed’s Elunate-Tyvyt Combo Receives Breakthrough Therapy Designation in China for Endometrial Cancer
HutchMed (China) Ltd (NASDAQ: HCM, HKG: 0013) has announced that the combination of Elunate (fruquintinib)...
Kintor Pharmaceutical Initiates Long-Term Safety Trial for Androgenetic Alopecia Treatment KX-826
China-based Kintor Pharmaceutical Ltd (HKG: 9939) has announced the start of the long-term safety trial...
Hybribio Ltd and United Imaging Healthcare Form Strategic Partnership to Advance Medical Technology
Guangdong-based Hybribio Ltd (SHE: 300639), a leading provider of nucleic acid molecular diagnostic products, has...
Novomics Partners with TopGene to Expand Genomic Testing Services in China
South Korea-based molecular diagnostics firm Novomics Co. has announced a strategic partnership with China-based Hubei...
Stemirna Therapeutics Halts mRNA Vaccine Factory Construction Amid Low Demand
China-based Stemirna Therapeutics Co., Ltd has decided to halt the construction of a factory intended...
BGI Genomics Partners with Thai Entities to Combat Thalassemia through Genomics and Cell Therapy
China-based genomics leader BGI Genomics Co., Ltd (SHE: 300676) has entered into a memorandum of...
Shanghai Junshi Biosciences’ Tuoyi Receives NMPA Review for ES-SCLC Treatment
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) has announced that the National Medical...
Sichuan Gowell Pharmaceutical Wins Reversal in Forxiga Patent Infringement Case
Sichuan Gowell Pharmaceutical Co., Ltd. has secured a favorable final judgment in its appeal against...
Boyu Capital Acquires Hong Kong Medical Device Company Quasar for Over $600 Million
Boyu Capital, according to a Bloomberg report, is set to acquire Quasar, a Hong Kong-based...
Novartis Q2 2023 Results Exceed Expectations with 9% YOY Sales Growth
Swiss pharmaceutical major Novartis AG (NYSE: NVS) has reported its financial results for the second...